FMR CORP 13D and 13G filings for ACADIA Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
FMR CORP | 5,265,357 3.207% |
-4,069,256 (-43.59%) |
Filing |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
FMR CORP | 9,334,613 5.764% |
-4,506,137 (-32.56%) |
Filing |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
FMR CORP | 13,840,750 8.609% |
-5,632,163 (-28.92%) |
Filing |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
FMR CORP | 19,472,913 12.248% |
-1,418,004 (-6.79%) |
Filing |